Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Citroking-HD is a nutraceutical combination supplement developed and marketed by Healthon Lifesciences. It is formulated to address deficiencies in calcium and vitamin D3, which are critical for maintaining bone density, dental health, and immune function. The supplement typically contains calcium citrate malate, a highly bioavailable form of calcium; vitamin D3 (cholecalciferol), which acts as an agonist at the vitamin D receptor to enhance intestinal calcium absorption; and mecobalamin (methylcobalamin), a coenzyme form of vitamin B12 that supports neurological health and DNA synthesis. Some formulations may also include L-methylfolate and pyridoxal 5-phosphate. Citroking-HD is available as an oral tablet and is used primarily for the management of nutritional deficiencies and the support of overall musculoskeletal health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Citroking-HD.